A detailed history of Banc First Trust & Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Banc First Trust & Investment Management holds 432 shares of LLY stock, worth $353,777. This represents 0.13% of its overall portfolio holdings.

Number of Shares
432
Previous 771 43.97%
Holding current value
$353,777
Previous $698,000 45.27%
% of portfolio
0.13%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$772.14 - $960.02 $261,755 - $325,446
-339 Reduced 43.97%
432 $382,000
Q2 2024

Jul 08, 2024

BUY
$724.87 - $909.04 $110,905 - $139,083
153 Added 24.76%
771 $698,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $24,343 - $33,560
56 Added 9.96%
618 $331,000
Q2 2023

Jul 05, 2023

BUY
$350.74 - $468.98 $197,115 - $263,566
562 New
562 $263,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Banc First Trust & Investment Management Portfolio

Follow Banc First Trust & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banc First Trust & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Banc First Trust & Investment Management with notifications on news.